Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine 2022-03-14 20:00
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting 2022-03-10 07:00
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 2022-03-09 07:47
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer 2022-03-09 06:58
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022 2022-03-09 05:30
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies 2022-03-08 08:00
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases 2022-03-08 08:00
Singleron Acquires Proteona 2022-03-07 23:00
Alterity Therapeutics to Present at the 34th Annual Roth Conference 2022-03-07 20:59
TCI Enters into Strategic Alliance with VeCollal(R) and CDMO the World's First, Science-based vegan collagen alternative 2022-03-07 16:00
Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect 2022-03-07 15:57
Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy 2022-03-04 21:00
Genome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients 2022-03-04 09:30
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers 2022-03-04 08:00
Claudin18.2 CAR T Cells (CT041) Receives Approval to Initiate A Confirmatory Phase II Clinical Trial for advanced GC/GEJ in China 2022-03-03 21:50
Akeso Announces Clinical Trial Collaboration with Chipscreen Biosciences to Evaluate Cadonilimab in Combination with Chiauranib for Extensive-Stage Small-Cell Lung Cancer 2022-03-03 01:34
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 2022-03-02 20:00
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China 2022-03-02 10:37
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
1 86 87 88 89 90 222